River Street Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
River Street Advisors's BMY Position: Q2 2026 in Review
River Street Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 4,945 shares — an estimated $300K sold.
River Street Advisors first reported a position in BMY in Q4 2022 and held it in 6 quarters. The position peaked at $802K in Q4 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- River Street Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- River Street Advisors sold 4,945 Bristol-Myers Squibb shares in Q2 2026, an estimated $300K.
- River Street Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 6 quarters.
- River Street Advisors's Bristol-Myers Squibb position peaked at $802K in Q4 2022.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on River Street Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.